- Do you own shares of Santarus, Inc. (NASDAQ GS: SNTS )?
- Did you purchase any of your shares prior to November 7, 2013?
- Do you think the proposed buyout price is too low?
- Do you want to discuss your rights?
Buyer views target's diabetes and heartburn treatments as complementary to its drug lineup.